NIH-funded research NIH-funded research

Antibiotics, the immune system, and gut health in kids with allergic reactions

Official title: Antibiotics, innate immunity, and dysbiosis in pediatric urticarial reactions

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11374155 · Data updated 2026-11-12

This grant explores how antibiotics and gut health may trigger itching rashes and other reactions in children, aiming to improve understanding and care for SSLR-like symptoms.

More Dysbiosis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJuly 17, 2025
Project endJune 30, 2027
Funding year2026
Award (this year)$401,250
NIH project number5UG3AI190045-02
Project IDNIH-11374155 on NIH RePORTER

Who could benefit from this research

Could help

Children aged 0-11 who experience antibiotic-associated reactions, including hives, facial swelling, fever, and joint symptoms, with non-diagnostic traditional allergy testing.

Less likely to help

Children without a history of antibiotic-associated reactions or who do not fit the study’s cohorts may not benefit from this research.

What this research studies

This project focuses on children aged 0-11 who experience antibiotic-associated skin and immune reactions. Using a multi-omics approach, researchers will examine blood inflammation markers, immune gene activity, gut bacteria, and metabolic changes to see how these factors relate to reactions like hives and joint pain. The study compares two groups of children to identify patterns that precede or accompany these reactions, especially when standard allergy tests are negative. The goal is to uncover non-traditional mechanisms behind these events and guide better prevention and treatment strategies for affected families.

Why it matters

Potential benefit: If successful, findings could lead to better prediction, prevention, and management of antibiotic-associated reactions in children, reducing distress and unnecessary allergy treatments.

How similar studies have gone: Previous work suggests complex, non-traditional pathways; this project proposes a novel, integrated multi-omics approach to clarify mechanisms.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Risma, Kimberly a — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Risma, Kimberly a

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.